Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats

被引：0
|
作者：
Shohei Yamada
Jun Tanabe
Yuji Ogura
Yoshio Nagai
Takeshi Sugaya
Keiichi Ohata
Yasunori Natsuki
Daisuke Ichikawa
Shiika Watanabe
Kazuho Inoue
Seiko Hoshino
Kenjiro Kimura
Yugo Shibagaki
Atsuko Kamijo-Ikemori
机构：
[1] St. Marianna University School of Medicine,Division of Nephrology and Hypertension, Department of Internal Medicine
[2] St. Marianna University School of Medicine,Department of Physiology
[3] St. Marianna University School of Medicine,Division of Metabolism and Endocrinology, Department of Internal Medicine
[4] St. Marianna University School of Medicine,Institute for Ultrastructural Morphology
[5] St. Marianna University School of Medicine,Department of Anatomy
[6] JCHO Tokyo Takanawa Hospital,undefined
来源：
Clinical and Experimental Nephrology | 2021年 / 25卷
关键词：
Diabetes; Diabetic kidney disease (DKD); GLP-1; GLP-1 receptor; Liraglutide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 375
页数：10
相关论文
共 50 条
  • [21] Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist, liraglutide, on an inflammatory-mediated diabetic non-human primate model
    Navabi, Roghayeh
    Negahdari, Babak
    Hajizadeh-Saffar, Ensiyeh
    Hajinasrollah, Mostafa
    Jenab, Yaser
    Rabbani, Shahram
    Pakzad, Mohamad
    Hassani, Seyedeh-Nafiseh
    Hezavehei, Maryam
    Jafari-Atrabi, Mohammad
    Tahamtani, Yaser
    Baharvand, Hossein
    LIFE SCIENCES, 2021, 276
  • [22] The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy
    Varadhan, Lakshminarayanan
    Humphreys, Tracy
    Walker, Adrian B.
    Varughese, George I.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) : E37 - E39
  • [23] The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists
    van Baar, Michael J. B.
    van der Aart, Annemarie B.
    Hoogenberg, Klaas
    Joles, Jaap A.
    Heerspink, Hiddo J. L.
    van Raalte, Daniel H.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2019, 10
  • [24] GLP-1 analog liraglutide attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin-induced diabetic rats
    Li Cairong
    Yu, Hui
    Gan, Shou-yi
    Zhao, Xin-yuan
    Zeng, Ling-yong
    Huang, Hong-xia
    Cai, Fei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C40 - C40
  • [25] Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist
    Namekawa, Junichi
    Nemoto, Sayaka
    Sunada, Gaku
    Takanashi, Yuki
    Fujio, Sakurako
    Shirai, Mitsuyuki
    Asai, Fumitoshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2018, 80 (10) : 1515 - 1523
  • [26] Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy in vivo and in vitro
    Liu, Jufen
    Wang, Huijing
    Huang, Cuiting
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2025, 131 (01) : 1 - 10
  • [27] Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Li, Jiahua
    Albajrami, Oltjon
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (11): : 1678 - 1688
  • [28] The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system
    Yang, Zheng
    Yu, Meng
    Mei, Mei
    Chen, Chongxin
    Lv, Yuhuan
    Xiang, Linyu
    Li, Rong
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (02) : 504 - 510
  • [29] Effect of GLP-1 Receptor Agonist on Ischemia Reperfusion Injury in Rats with Metabolic Syndrome
    Ravic, Marko
    Srejovic, Ivan
    Novakovic, Jovana
    Andjic, Marijana
    Sretenovic, Jasmina
    Muric, Maja
    Nikolic, Marina
    Bolevich, Sergey
    Kasabov, Kirill Alekseevich
    Fisenko, Vladimir Petrovich
    Stojanovic, Aleksandra
    Jakovljevic, Vladimir
    PHARMACEUTICALS, 2024, 17 (04)
  • [30] Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: Role of GLP-1 and GLP-1 receptor
    Abd El Motteleb, Dalia M.
    Elshazly, Shimaa M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 720 (1-3) : 158 - 165
12345